These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 2681479)

  • 1. Plasma homocysteine, a risk factor for vascular disease: plasma levels in health, disease, and drug therapy.
    Ueland PM; Refsum H
    J Lab Clin Med; 1989 Nov; 114(5):473-501. PubMed ID: 2681479
    [No Abstract]   [Full Text] [Related]  

  • 2. Homocysteine, vitamin status and risk of vascular disease; effects of gender and menopausal status. European COMAC Group.
    Verhoef P; Meleady R; Daly LE; Graham IM; Robinson K; Boers GH
    Eur Heart J; 1999 Sep; 20(17):1234-44. PubMed ID: 10454975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homocysteinemia: new information about an old risk factor for vascular disease.
    Engman M
    J Insur Med; 1998; 30(4):231-6. PubMed ID: 10537928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormones and homocysteine.
    Asnani S; Desouza C; Homan J; Murthy SN; McNamara DB; Fonseca V
    Minerva Endocrinol; 2002 Sep; 27(3):141-55. PubMed ID: 12091790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Can blood homocysteine explain the family history of vascular diseases?].
    Reis RP; Gomes E; Duarte R; Correia MJ; Cândido A; Reis HP; Azinheira J; Pina JE; Correia JM; Luís AS
    Rev Port Cardiol; 2001 Apr; 20(4):413-8. PubMed ID: 11433886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocysteinaemia: a newly recognized risk factor for vascular disease.
    Boers GH
    Neth J Med; 1994 Jul; 45(1):34-41. PubMed ID: 8065483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteinaemia after methionine overload as a coronary artery disease risk factor: importance of age and homocysteine levels.
    Reis RP; Azinheira J; Reis HP; Bordalo A; Santos L; Adao M; Pina JE; Ferreira NC; Luis AS
    Coron Artery Dis; 1995 Nov; 6(11):851-6. PubMed ID: 8696529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interrelations between plasma homocysteine and intracellular S-adenosylhomocysteine.
    Fu W; Dudman NP; Perry MA; Young K; Wang XL
    Biochem Biophys Res Commun; 2000 Apr; 271(1):47-53. PubMed ID: 10777679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hyperhomocysteinemia: a new independent vascular risk factor?].
    Cafagna D; Ponte E
    Minerva Cardioangiol; 1997; 45(1-2):49-55. PubMed ID: 9213816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Homocysteinemia as a risk factor for vascular disease-which patients should be treated?].
    Reis RP; Azinheira J; Reis HP; Bordalo-Sá AL; Santos L; Tavares J; Adão M; Pina JE; Correia JM; Luís AS
    Rev Port Cardiol; 1998 Jan; 17(1):63-6. PubMed ID: 9580508
    [No Abstract]   [Full Text] [Related]  

  • 11. Performance comparison of three assay methods used in fasting and postmethionine load plasma homocysteine determinations from patients with vascular disease.
    Mourvaki E; Ferrante F; Ghirarduzzi A; Brini M; Depunzio I; Iorio A
    Am J Clin Pathol; 2005 Nov; 124(5):675-81. PubMed ID: 16203288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia as a risk factor for arterial and venous disease. A review of evidence and relevance.
    Boers GH
    Thromb Haemost; 1997 Jul; 78(1):520-2. PubMed ID: 9198207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Deregulation of homocysteine metabolism and consequences for the vascular system].
    Nicolas JP; Chango A
    Bull Acad Natl Med; 1997 Feb; 181(2):313-29; discussion 330-1. PubMed ID: 9235230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease.
    Moat SJ; Bonham JR; Powers HJ
    Clin Sci (Lond); 2001 Jan; 100(1):73-9. PubMed ID: 11115421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hyperhomocysteinemia--a risk factor or vascular disease?].
    Bar-Meir E; George J; Shoenfeld Y
    Harefuah; 1999 Jan; 136(2):129-33. PubMed ID: 10914181
    [No Abstract]   [Full Text] [Related]  

  • 16. [Plasma homocysteine, a risk factor for premature vascular disease. Plasma levels in healthy persons; during pathologic conditions and drug therapy].
    Ueland PM; Refsum H
    Nord Med; 1989; 104(11):293-8. PubMed ID: 2813054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hyperhomocysteinemia as a risk factor for vascular diseases].
    Ziegler R
    Med Monatsschr Pharm; 2006 Jun; 29(6):228-9. PubMed ID: 16792202
    [No Abstract]   [Full Text] [Related]  

  • 18. [Homocysteine metabolism and risk of cardiovascular diseases: importance of the nutritional status on folic acid, vitamins B6 and B12].
    Alemán G; Tovar AR; Torres N
    Rev Invest Clin; 2001; 53(2):141-51. PubMed ID: 11421110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Unaltered homocysteine levels during simvastatin therapy].
    Sinzinger H; Chehne F; Schmid P; Kritz H
    Wien Klin Wochenschr; 2000 Jun; 112(12):540-3. PubMed ID: 10953872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis.
    Nilsson K; Gustafson L; Hultberg B
    Dement Geriatr Cogn Disord; 2007; 24(3):162-8. PubMed ID: 17641526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.